Literature DB >> 15047800

Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.

Sabine Vollstedt1, Susi Arnold, Cornelia Schwerdel, Marco Franchini, Gottfried Alber, James P Di Santo, Mathias Ackermann, Mark Suter.   

Abstract

The essential components of the immune system that control primary and chronic infection with herpes simplex virus type 1 (HSV-1) in mice were investigated. Infection within the first few days can be controlled by alpha/beta interferon (IFN-alpha/beta) alone without significant contribution of B, T, or NK cells. IFN-alpha/beta and IFN-gamma cooperate in the elimination of virus in the absence of these lymphocytes. In contrast, B, T, or NK cells appear to be required to control persistent infection with HSV-1. These results suggest that distinct and essential immune elements are recruited in a time-dependent fashion to control acute and persistent HSV-1 infection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047800      PMCID： PMC374284          DOI： 10.1128/jvi.78.8.3846-3850.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

Authors:  Giorgio Trinchieri; Stefan Pflanz; Robert A Kastelein
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

2.  Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency.

Authors:  H Minagawa; Y Yanagi
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

3.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  The dendritic, Thy-1-positive cell of murine epidermis: a new epidermal cell type of bone marrow origin.

Authors:  G Schuler
Journal:  J Invest Dermatol       Date:  1984-08       Impact factor: 8.551

5.  BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1.

Authors:  M Suter; A M Lew; P Grob; G J Adema; M Ackermann; K Shortman; C Fraefel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

Authors:  H Hochrein; K Shortman; D Vremec; B Scott; P Hertzog; M O'Keeffe
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus.

Authors:  M Franchini; C Abril; C Schwerdel; C Ruedl; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  A new immunodeficient mouse model for human myoblast transplantation.

Authors:  R N Cooper; A Irintchev; J P Di Santo; M Zweyer; J E Morgan; T A Partridge; G S Butler-Browne; V Mouly; A Wernig
Journal:  Hum Gene Ther       Date:  2001-05-01       Impact factor: 5.695

9.  Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice.

Authors:  J A Lekstrom-Himes; R A LeBlanc; L Pesnicak; M Godleski; S E Straus
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

10.  In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.

Authors:  S Habu; K Akamatsu; N Tamaoki; K Okumura
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422
View more
  46 in total

1.  Δγ₁134.5 herpes simplex viruses encoding human cytomegalovirus IRS1 or TRS1 induce interferon regulatory factor 3 phosphorylation and an interferon-stimulated gene response.

Authors:  Kevin A Cassady; Ute Saunders; Masako Shimamura
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.

Authors:  Lianghua Bin; Michael G Edwards; Ryan Heiser; Joanne E Streib; Brittany Richers; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

3.  Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.

Authors:  Mina Kalantari-Dehaghi; Sookhee Chun; Aziz Alami Chentoufi; Jozelyn Pablo; Li Liang; Gargi Dasgupta; Douglas M Molina; Algis Jasinskas; Rie Nakajima-Sasaki; Jiin Felgner; Gary Hermanson; Lbachir BenMohamed; Philip L Felgner; D Huw Davies
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

4.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

5.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

6.  Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1.

Authors:  Sadik H Kassim; Naveen K Rajasagi; Barry W Ritz; Stephen B Pruett; Elizabeth M Gardner; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 8.  Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons.

Authors:  Diane E Griffin
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

9.  Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.

Authors:  Kathryne E Taylor; Marianne V Chew; Ali A Ashkar; Karen L Mossman
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.

Authors:  Yijun Du; Jing Qi; Yu Lu; Jiaqiang Wu; Dongwan Yoo; Xing Liu; Xiumei Zhang; Jun Li; Wenbo Sun; Xiaoyan Cong; Jianli Shi; Jinbao Wang
Journal:  Virus Genes       Date:  2012-07-28       Impact factor: 2.332
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.